Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Grants
$3M
2 grants · CORDIS
Backers
1
Occident
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | Switzerland Resistell AG | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Occident Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Our Mission and Innovation We are a biotechnology pioneer dedicated to solving one of the greatest challenges in modern medicine: the…
Arrowsmith Inc. is a research-driven biotech focused on bringing next-generation phage therapy into clinical use for patients suffering…
Lantern uses cutting-edge machine learning to guide what, when, and how distributors buy.
Welcome to SimplyCast, your all-in-one hyperautomation solution.
Gyre Therapeutics. Welcome to Gyre Therapeutics.
Nosis Bio delivers breakthrough receptor-targeted RNA medicines through cutting-edge physics-aware deep learning, single cell biology, and…
News
The imperative of ultra-rapid Antibiotic Susceptibility Testing
Antibiotic treatments are often preemptively initiated without knowing the antibiotic resistance profile of the causative pathogen. This leads to potentially inappropriate therapies. Ultra-rapid Antibiotic Susceptibility Testing (AST) is key in identifyin
Read more
Report
Uncovering the hidden cost of delayed antibiotic resistance results
Immediate financial and clinical impact of Antibiotic Resistance
Read more
Report
Nature Communications publishes Resistell's groundbreaking AST platform
Resistell, an EPFL spin-off developing rapid phenotypic antibiotic susceptibility testing (AST) solutions, announces the peer-reviewed article in the Nature Communications journal. The publication marks the completion of the company's technology validatio
Read more
Report
Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform
Antimicrobial resistance (AMR) is a major public health threat, reducing treatment options for infected patients. AMR is promoted by a lack of access to rapid antibiotic susceptibility tests (ASTs). Accelerated ASTs can identify effective antibiotics for
Read more
Report
Please join us in welcoming Trevor Hawkins to our Board of Directors at Resistell!
With a remarkable 25-year journey at the forefront of healthcare innovation, Trevor brings a wealth of experience from his leadership roles across research, clinical, and corporate spheres globally. His track record of innovation, coupled with a profound
Read more
Report
Cellectric, Resistell and Lausanne University Hospital will collaborate on a joint Eurostars project
Cellectric, Resistell and Lausanne University Hospital will collaborate on a joint Eurostars project to build Phenotech-CF, a workflow that will reshape how antimicrobials are delivered to patients suffering from cystic fibrosis.
Read more
Report
Watch our webcast with Nature on Nanomotion Technology for Ultrarapid Antibiotic Susceptibility Testing
Our latest webcast with Nature is now available for replay. Join us as we delve into the science behind nanomotion technology and its application in real-world healthcare settings. Learn about Resistell's groundbreaking technology platform that leverages
Read more
Report
Resistell among TOP 10 best start-ups 2023 in Switzerland
TOP 100 Swiss Startup Award has become a benchmark in Switzerland's startup ecosystem. The award show connects the most promising Swiss startups with Swiss and international investors, executives, and journalists. The invitation-only Award Night has becom
Read more
Report
A new method for detecting bacterial susceptibility to antibiotics
Scientists from EPFL and Vrije Universiteit Brussel have been working for several years on a new nanomotion based method to detect bacterial sensitivity to antibiotics. In essence, it involves "watching the bacteria dance". Joining Stéphane Gabioud and jo
Read more
Report
Show more news